Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer. | Int J Mol Sci | 2022 | 35887085 | PubTator, text mining | PubMed |
| Emerging Roles and Potential Applications of Non-Coding RNAs in Cervical Cancer. | Genes (Basel) | 2022 | 35886037 | PubTator, text mining | PubMed |
| Identifying Genes Related to Acute Myocardial Infarction Based on Network Control Capability. | Genes (Basel) | 2022 | 35886020 | PubTator, text mining | PubMed |
| Long non-coding RNA in prostate cancer. | Am J Clin Exp Urol | 2022 | 35874287 | PubTator, text mining | PubMed |
| Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. | Front Pharmacol | 2022 | 35873564 | PubTator, text mining | PubMed |
| Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer. | Genes Dis | 2022 | 35873034 | PubTator, text mining | PubMed |
| FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway. | Balkan Med J | 2022 | 35872627 | PubTator, text mining | PubMed |
| Role of circulating long non-coding RNA for the improvement of the predictive ability of the CHA 2 DS 2 -VASc score in patients with atrial fibrillation. | Chin Med J (Engl) | 2022 | 35869861 | PubTator, text mining | PubMed |
| Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy. | Front Oncol | 2022 | 35860590 | PubTator, text mining | PubMed |
| LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization. | Front Neurosci | 2022 | 35860297 | PubTator, text mining | PubMed |
| Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review). | Oncol Rep | 2022 | 35856447 | PubTator, text mining | PubMed |
| Novel lncRNAs with diagnostic or prognostic value screened out from breast cancer via bioinformatics analyses. | PeerJ | 2022 | 35855425 | PubTator, text mining | PubMed |
| Two lncRNAs, MACC1-AS1 and UCA1, co-mediate the expression of multiple mRNAs through interaction with individual miRNAs in breast cancer cells. | Noncoding RNA Res | 2022 | 35846076 | PubTator, text mining | PubMed |
| Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma. | Front Oncol | 2022 | 35837094 | PubTator, text mining | PubMed |
| Suppression of Long Noncoding RNA SNHG1 Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma via Increasing PARP6 Expression. | Evid Based Complement Alternat Med | 2022 | 35836822 | PubTator, text mining | PubMed |
| PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p/CDK4 axis. | Oncol Lett | 2022 | 35814832 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies. | Front Oncol | 2022 | 35814444 | PubTator, text mining | PubMed |
| EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player? | Front Oncol | 2022 | 35814425 | PubTator, text mining | PubMed |
| Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer. | Front Pharmacol | 2022 | 35814205 | PubTator, text mining | PubMed |
| Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers. | Front Mol Biosci | 2022 | 35813829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=40